Case Study: Metformin-Associated Lactic Acidosis
- 1 August 2003
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 26 (8) , 2471-2472
- https://doi.org/10.2337/diacare.26.8.2471
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Pharmacokinetic Evaluation of the Possible Interaction between Selected Concomitant Medications and Orlistat at Steady State in Healthy SubjectsThe Journal of Clinical Pharmacology, 2002
- Effect of Orlistat in Overweight and Obese Patients With Type 2 Diabetes Treated With MetforminDiabetes Care, 2002
- Clinical Efficacy of Orlistat Therapy in Overweight and Obese Patients With Insulin-Treated Type 2 DiabetesDiabetes Care, 2002
- Principles for Enhanced Recruitment of Subjects in a Large Clinical Trial: The XENDOS Study ExperienceControlled Clinical Trials, 2001
- Lactic acidosis in metformin therapy.Drugs, 1999
- Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patientsPublished by Elsevier ,1998
- An Overview of Metformin in the Treatment of Type 2 Diabetes MellitusThe American Journal of Medicine, 1997
- Role of Metformin Accumulation in Metformin-Associated Lactic AcidosisDiabetes Care, 1995
- Effect of metformin on glucose metabolism in the splanchnic bedBritish Journal of Pharmacology, 1992
- Reduction of metformin renal tubular secretion by cimetidine in man.British Journal of Clinical Pharmacology, 1987